arrow
C

Charlotte M. Niemeyer

University of Freiburg
H指数:80
被引数:2.6万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia

再生障碍性贫血中克隆造血和结构变异的高分辨率单细胞定位

2026-05-010
PRE
ADVANCED DRUG RESPONSE PROFILING AND IMMUNOPHENOTYPING TO PRIORITIZE TREATMENT OPTIONS FOR PEDIATRIC MDS WITH EXCESS BLASTS
2025-11-010
OAAI
GENETIC LANDSCAPE AND OUTCOMES AFTER HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN AND ADOLESCENTS WITH THERAPY-RELATED MYELOID NEOPLASMS

治疗相关性髓系肿瘤儿童和青少年造血干细胞移植后的遗传景观和结局

2025-11-010
OA
IMPROVED ENGRAFTMENT FOLLOWING A TREOSULFAN-FLUDARABINE CONDITIONING REGIMEN COMPARED TO THIOTEPA-FLUDARABINE IN PATIENTS WITH REFRACTORY CYTOPENIA OF CHILDHOOD

与噻替帕-氟达拉滨相比,TREOSULFAN-氟达拉滨预处理方案改善了儿童难治性血细胞减少症患者的植入

2025-11-010
OAAI
OUTCOMES OF RABBIT VS. HORSE ANTI-THYMOCYTE GLOBULIN IN IMMUNOSUPPRESSIVE THERAPY FOR REFRACTORY CYTOPENIA OF CHILDHOOD
2025-11-010
OAAI
LONG-TERM OUTCOME OF AN OBSERVATIONAL APPROACH IN PATIENTS WITH NRAS-MUTATED JUVENILE MYELOMONOCYTIC LEUKEMIA AND ABSENCE OF HIGH RISK FEATURES
2025-11-010
OA
INTEGRATED IMMUNOPHENOTYPING AND DRUG RESPONSE PROFILING REVEALS SUBTYPE-SPECIFIC SUSCEPTIBILITIES IN PEDIATRIC MDS WITH EXCESS BLASTS
2025-11-010
OA
PUMA-induced apoptosis drives bone marrow failure and genomic instability in telomerase-deficient mice

PUMA诱导的细胞凋亡导致端粒酶缺陷小鼠的骨髓衰竭和基因组不稳定性

2025-08-190
OA
Assessment of peripheral blood DNA methylation signatures as pharmacodynamic and predictive biomarkers during azacitidine therapy in juvenile myelomonocytic leukaemia: Results of the EWOG-MESRAT study

评估外周血DNA甲基化特征作为阿扎胞苷治疗儿童髓系单核细胞白血病期间药效学和预测性生物标志物的应用:EWOG-MESRAT研究的结果

2025-07-310
OAAI
Age-dependent phenotypic and molecular evolution of pediatric MDS arising from GATA2 deficiency

年龄依赖性的表型和分子进化:源于GATA2缺乏的儿科MDS

2025-07-150
OAAI
Long-term outcome of patients with refractory cytopenia of childhood under observation-only

儿童难治性血细胞减少症患者在仅观察下的长期预后

2025-07-070
OAAI
Somatic RIT1 delins in arteriovenous malformations hyperactivate RAS-MAPK signaling amenable to MEK inhibition
2024-07-050
OAAI